Title:
細胞性及び体液性免疫を達成するためのヒト間葉系幹細胞を使用する方法
Document Type and Number:
Japanese Patent JP7276664
Kind Code:
B2
Abstract:
The present invention provides a method of treating subjects with non-ischemic dilated cardiomyopathy by administering a therapeutically effective amount of an isolated population of allogeneic human mesenchymal stem cells. The present invention also provides a method of treating subjects with symptoms of aging frailty by administering a therapeutically effective amount of an isolated population of allogeneic human mesenchymal stem cells.
More Like This:
Inventors:
Halle, Joshua M.
Landin, Anamarie
Landin, Anamarie
Application Number:
JP2019524319A
Publication Date:
May 18, 2023
Filing Date:
November 10, 2017
Export Citation:
Assignee:
Long Ever on Incorporated
International Classes:
G01N33/53; C12Q1/06
Domestic Patent References:
| JP2013536860A | ||||
| JP2016516985A |
Other References:
RBMOnline,2008年,Vol. 16, No. 6,pp. 898-905
Circulation Research,2015年,Vol. 117,pp. 576-584
JAMA,2012年,Vol. 308, No. 22,pp. 2369-2379
Circulation Research,2015年,Vol. 117,pp. 576-584
JAMA,2012年,Vol. 308, No. 22,pp. 2369-2379
Attorney, Agent or Firm:
Ikeda Adult
Junichiro Sakamaki
Masakazu Noda
Katsusuke Kimoto
Yuji Wada
Junichiro Sakamaki
Masakazu Noda
Katsusuke Kimoto
Yuji Wada
Previous Patent: Dielectric compositions and electronic components
Next Patent: Active ester composition and semiconductor encapsulation material
Next Patent: Active ester composition and semiconductor encapsulation material